CompletedNot Applicable

Intervention for Human Papillomavirus Vaccine Acceptance in Mexican Mothers

Mexico10 participantsStarted 2021-12-07

Plain-language summary

Randomized clinical trial with two groups, with a test-retest model, with single-blind approach, using a probabilistic sampling and the population was mothers of girls aged 9 to 12 years from a public elementary school in the state of Puebla. The objective was to determine the effect of the intervention "Vaccine for HPV Prevention" aimed at the acceptance of the HPV vaccine in mothers of girls aged 9 to 12 years old in the urban area of the State of Puebla.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women from 20 to 59 years old. * Mothers of girls from 9 to 11 years old. * Who agree to participate in the study. * Who know how to read and write. * Who have an electronic device (cell phone, tablet or computer). * That they have access to social networks such as WhatsApp and Facebook. * That they have an internet connection. Exclusion Criteria: * Mothers with a history of CACU and/or HPV infection in themselves or a family member. * Mothers who have received information about CACU, HPV and/or the HPV vaccine at least one month prior to the educational intervention.

What they're measuring

knowledge of HPV

Timeframe: 3 months

Positive and negative beliefs about HPV and the vaccine

Timeframe: 3 months

Acceptance of the human papillomavirus vaccine

Timeframe: 3 months

Trial details

NCT IDNCT06854354

SponsorHospital Univeristario Benemerita Universidad Autonoma de Puebla

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-02-01

View on ClinicalTrials.gov More Papillomavirus Infections trials